Bruker Corporation, a leading provider of scientific instruments and solutions, recently unveiled its groundbreaking neofleX MALDI-TOF/TOF system at the 72nd ASMS meeting in Anaheim, California. This innovative system is designed to facilitate tissue imaging using mass spectrometry, ultimately enabling research in the field of spatial biology. With the introduction of the neofleX Imaging Profiler, Bruker aims to bring significant advancements in MALDI-TOF technology by providing enhanced performance and a more user-friendly laboratory tool.
Key Features of the neofleX MALDI-TOF System
The neofleX MALDI-TOF/TOF system offers unprecedented capabilities in mass spectrometry-based tissue imaging. Perhaps, one of the most notable features is its high-performance design, allowing for improved accuracy and precision in molecular analysis. The sophisticated neofleX Imaging Profiler is capable of generating OME-TIFF file output, enabling seamless integration with the recently developed SCiLS Scope software. This capability streamlines the imaging process and enhances data interpretation.
Enhanced Convenience and Accessibility
Bruker’s neofleX MALDI-TOF/TOF MSI system has been designed to empower researchers with greater convenience. By being bench-top compatible, the neofleX Imaging Profiler eliminates the need for dedicated laboratory space, making it accessible to a wider range of users. With this development, Bruker aims to democratize the use of mass spectrometry for spatial biology and encourage more researchers to explore the realm of tissue imaging.
Proprietary Technology
The neofleX Imaging Profiler MALDI-TOF/TOF mass spectrometer is furnished with Bruker’s proprietary technology, offering unmatched capabilities in tissue imaging research. This system is equipped with high-resolution optics and advanced algorithms, enabling researchers to capture detailed molecular images with improved spatial resolution and sensitivity. By combining the advantages of MALDI-TOF/TOF technology and Bruker’s proprietary tools, the neofleX system represents a significant milestone in spatial biology mass spectrometry.
Conclusion:
With the unveiling of the neofleX MALDI-TOF system, Bruker Corporation has taken a significant step forward in advancing mass spectrometry-based tissue imaging for spatial biology. By providing researchers with a more user-friendly and convenient bench-top solution, Bruker aims to empower the scientific community to delve deeper into the fascinating world of spatial biology. The neofleX Imaging Profiler’s high-performance design and proprietary technology offer unparalleled accuracy and sensitivity, unlocking new possibilities in tissue analysis and molecular imaging research.
Comments